Compound ID | 1340

Update compound information

Pivmecillinam

Synonym(s): Pivya  |  Amdinocillin pivoxil  |  Selexid  |  Penomax  |  Coactabs

Class: Beta-lactam

Agent Type: Semisynthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-negative
Mechanism of action: Cell wall synthesis inhibitor. Penicillin binding protein 2 inhibitor (PBP-2 inhibitor)
Target Pathogen: Active against Enterobacteriaceae including ESBL producers
Description: Prodrug of mecillinam/ amdinocillin. Used for oral therapy of urinary tract infections.
Institute where first reported: Leo Pharmaceutical Products; Utility Therapeutics
Year first mentioned: 1975
Highest development stage: Approved by FDA in 2024
Development status: Approved
Chemical structure(s):
Click here for structure editor
Molecular weight: 439.57
Iso. SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)OCOC(=O)C(C)(C)C)C
InChI Key: NPGNOVNWUSPMDP-HLLBOEOZSA-N
Can. SMILES: CC(C)(C)C(=O)OCOC(=O)[C@H]1C(C)(C)S[C@@H]2[C@@H](C(=O)N12)N=CN3CCCCCC3
InChI: InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/t14-,15+,17-/m1/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/115163
Guide to Pharmacology: pivmecillinam
Citations:
  • https://academic.oup.com/jac/article/46/suppl_1/35/2473592
  • https://pubmed.ncbi.nlm.nih.gov/30518669/
  • https://pubmed.ncbi.nlm.nih.gov/1157572/
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC9118732/
  • https://doi.org/10.1093/jac/dky230

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.